Tech Company Financing Transactions
Resurrect Bio Funding Round
Resurrect Bio secured a $2.3 million Series A funding round on 5/13/2026. Backers included Corteva, AgFunder and Calculus Capital.
Transaction Overview
Company Name
Announced On
5/13/2026
Transaction Type
Venture Equity
Amount
$2,300,000
Round
Series A
Investors
Proceeds Purpose
The funds will be spent on growing the team and developing disease resistance traits in economically important crops.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Sir Alexander Fleming Building, Imperial College London
London, England, SW7 2AZ
UK
London, England, SW7 2AZ
UK
Phone
Undisclosed
Website
Email Address
Overview
Resurrect Bio is a plant biotech start-up, based in London. We will improve the immune system of crop species. Climate change is causing diseases to spreading to new locations, meaning the disease spectrum farmers are dealing with is expanding. Crops were bred over generations by plant breeders to improve key traits such as yield, height or drought-tolerance, but sometimes inadvertently lost key immune resistance genes (R-genes).
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Cian Duggan
Co-Founder
Tolga Bozkurt
Browse more venture capital transactions:
Prev: 5/13/2026: Swarmer venture capital transaction
Next: 5/13/2026: Wispr AI venture capital transaction
Share this article
Where The Data Comes From
We report on all VC transactions involving tech companies. All VC database entries on this site are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs